CREATE ACCOUNT

Request Registration Code

Terms of Service

All messages posted at this site express the views of the author, and do not necessarily reflect the views of the owners and administrators of this site.

By registering at this site you agree not to post any messages that are obscene, vulgar, slanderous, hateful, threatening, or that violate any laws. We will permanently ban all users who do so.

We reserve the right to remove, edit, or move any messages for any reason.

  I agree to the terms of service

FORGOT YOUR DETAILS?

The Cryonics Institute’s 130th Patient

Monday, 30 March 2015 by System Administrator

CI patient #130 was a 70 year old male who died in a Michigan hospital on February 24th 2015 after being hospitalized for an extended amount of time.  The patient was a CI member at the time of his death.

 

The patient died at about 2pm on the 24th of February.  The nurses injected the patient with heparin, did chest compressions, packed his head in ice and then sent him to the hospital morgue.  CI was contacted and a CI employee, along with CI’s cooperating funeral director, Jim Walsh, went to the hospital and picked up the patient and brought him back to the CI facility.

 

The patient arrived at the CI facility at about 6pm.  Sara Walsh, CIs local cooperating funeral director, was present for the perfusion and the perfusion began at about 7:30pm.  No clotting of the blood was observed.  There was a lot of edema noted in the patient because the patient was on life support at the hospital for an extended period of time and the patient retained a lot of fluids.  

 

The perfusion was completed at 9:15pm.  During the perfusion there were 4 liters of 10% Eg solution, 8 liters of 30 % Eg solution and 65 liters of 70% VM1 solutions used.  The final refractive index of the effluents exiting the right jugular vein from the head was 1.4222.  The final refractive index of the effluents exiting the left jugular vein from the head was 1.420.  Considerable dehydration of the head and face was noted along with a considerable bronzing color of the skin.  The perfusion to the body did not produce saturation of the tissues with the cryoprotective solution due to the edema in the body.

 

The patient was then placed in the computer controlled cooling chamber to cool to liquid nitrogen temperature.  The human vitrification program was selected and the patient was cooled to liquid nitrogen temperature over a period of almost six days.  The patient was then placed in a cryostat for long-term cryonic storage.

 

 

 

Comments:  The patient’s son was present at the hospital and he was very supportive and instrumental in his father’s cryonics arrangements.  By being at the hospital, the patient’s son was able to secure the help of the nurses with injecting heparin, doing chest compressions and starting the patient cooling in ice.

The Cryonics Institute’s 129th Patient

Thursday, 5 February 2015 by System Administrator

Cryonics Institute Case Report for Patient Number 129

CI patient #129 was an 81 year old male from Maryland who died at home under hospice care on January 30th, 2015.  The patient was a CI member at the time of his death.

The patient had contracted with a local funeral director to provide initial cooling and transport services.  The patient died at approximately 10:30am on January 30, 2015.  The patient was packed in water ice and transported to the airport where he was then flown to the CI facility.  Heparin was not administered by the hospice providers or funeral director.

The patient arrived at the CI facility, packed in water ice at approximately 11:30pm on the 30th of January.  Jim and Sara Walsh, CIs local cooperating funeral directors, were both present for the perfusion and the perfusion began at about midnight.  Body perfusion was attempted, but because of clotting of the blood, the amount of cryoprotective solution that was absorbed into the body was minimal, though some dehydration and bronzing of the skin was observed in the upper arms and torso.

The perfusion was completed at 1:18am.  During the perfusion there were 5 liters of 10% Eg solution used, 8 liters of 30 % Eg solution used and 13 liters of 70% VM1 solutions used.  The flow rate during perfusion with 70% VM1 was .23 liters per minute with a pressure of 127mm.  The final refractive index of the effluents exiting the right jugular vein was 1.4128.  The final refractive index of the effluents exiting the left jugular vein were not measured because the funeral director could not place a drain tube in the jugular vein because the vein was smaller in size than normal.  Dehydration of the head and face was noted along with a bronzing color of the skin.  Some edema started to appear on the left side of the patient’s neck and face at the end of the perfusion.

The patient was then placed in the computer controlled cooling chamber to cool to liquid nitrogen temperature.  The human vitrification program was selected and the time needed to cool the patient to liquid nitrogen temperature was five days and 19 hours.  The patient was then placed in a cryostat for long-term cryonic storage.
 

The Cryonics Institute’s 128th Patient

Wednesday, 14 January 2015 by System Administrator

Cryonics Institute Case Report for Patient Number 128

CI patient #128 was a 32 year old female who died in Arizona on January 4th, 2015.  The cause of death was Acute Myelogenous Leukemia.  The patient was a CI member at the time of her death.

The next of kin had contracted with a local funeral director to provide initial cooling and transport services.  The patient died at approximately 6:30am on January 4th, 2015.  The patient was picked up by the cooperating funeral director and packed in water ice and was taken to the cooperating funeral directors facility, where she was maintained in water ice.  Heparin was not administered.

The patient arrived at the CI facility, packed in water ice at approximately 7:30pm on the 6th of January.  Jim and Sara Walsh, CIs local cooperating funeral directors, were both present for the perfusion and the perfusion began at 7:45pm.  No clotting of the blood was observed during the perfusion.  The body and head were both perfused and a flow rate of 1.66 liters per minute was maintained at 118mm pressure.

The perfusion was completed at 8:45pm.  During the perfusion there were 2 liters of 10% Eg solution used, 4 liters of 30 % Eg solution used and 30 liters of 70% VM1 solutions used.  The final refractive index of the effluents exiting the right jugular vein was 1.4168.  The final refractive index of the effluents exiting the left jugular vein was 1.40.  The perfusion was terminated before the desired refractive index of 1.424 was achieved because the flow from the jugular veins from the head decreased to the point of almost stopping and edema was starting to appear in the face.  No edema was noted in the body and bronzing of the skin and dehydration was noted all the way to the toes and finger tips.

The patient was then placed in the computer controlled cooling chamber to cool to liquid nitrogen temperature.  The human vitrification program was selected and the time needed to cool the patient to liquid nitrogen temperature was five days and 14 hours.  The patient was then placed in a cryostat for long-term cryonic storage.

Comments:  The state of Arizona will not issue any paperwork for transit on the weekends, and this caused a delay in getting the patient to CI. The perfusion went quite well, especially considering that there was about 60 hours of cold ischemia.  The reason for this could be that the patient was quickly packed in water ice and the patient was thin, which would allow the patient to cool down faster.  Less amounts of the 10% and 20% solutions were used in the perfusion because past experiences have shown that we can obtain better saturation of the tissue with vitrification solution, with less edema, if we use less amounts of the lower concentrations of solutions and advance quicker to the 70% solution when there is more than 24 hours of cold ischemia.  The reasons for no clotting of the blood, though no heparin was administered, are unclear.  It may be possible that the medications the patient was receiving as treatment for Leukemia helped to prevent coagulation, but at the time the report was written the types of medication the patient was receiving are unknown.

TOP